|
CAPR Capricor Therapeutics Inc 1133869 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-40,733,654.00 |
| Balance Sheet |
|
Current Assets
|
$242,127,977.00 |
|
Assets
|
$368,735,835.00 |
|
Current Liabilities
|
$32,961,421.00 |
|
Liabilities
|
$122,516,945.00 |
|
Equity
|
$246,218,890.00 |
|
Shares Out
|
58108989.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-60,740,078.00 |
|
Investing Cash Flow
|
$-203,399,644.00 |
| Market Analysis |
Market Cap
|
$397,465,484.76 |
|
Price
|
$9.06 |
|
BVPS
|
4.24 |
|
PB
|
1.61 |
|
EPS
|
-0.70 |
|
FCF
|
$-69,924,722.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:22 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.62 |
|
|
2026-05-12 |
-0.59 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.57 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.54 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CAPR documents filed with the SEC.
CAPR Filings
Clear
